ONC (BeiGene Oncology) Earnings per share growth in current year
Reviewing the annual earnings per share history for BeiGene Ltd (ONC) on GURU.Markets, it is evident that the metric remains at 236.50. BeiGene Ltd (ONC) dominates the development of targeted therapies through its global network of clinical trials. High R&D expenditures are offset by the scalability of its molecules, while stable demand for Brukinsa ensures a powerful cash flow.
Financial and market metric breakdowns for BeiGene Oncology (ONC)
- stock value and consensus price forecast:
- business market valuation indicators:
- book capitalization indicators:
- debt burden and liquidity indicators:
- company profitability and valuation multiples indicators:
ONC - Company Net Income|Expected Profit BeiGene Ltd|ONC - Price to Earnings Ratio|Market Cap to Future Earnings Ratio BeiGene Ltd|ONC - PEG Multiple|Enterprise Value to Operating Income Before Depreciation BeiGene Ltd|ONC - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months BeiGene|ONC - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months beigene.com|ONC - Earnings growth in current year|Expected earnings per share growth for next year BeiGene Ltd
- sales volume and revenue information:
Basic company analysis:BeiGene Corp
The global expansion of innovative oncology drugs from BeiGene Ltd (ONC) converts directly into growth in net income available to shareholders. This metric measures the percentage deviation of current earnings per share from the same period last year, allowing investors to assess the business scaling pace and the issuer's fundamental stability through year-over-year EPS dynamics.
Direct competitors
Halozyme Inc. - Earnings per share increase in current year|RVMD (Revolution Medicines Inc) - Earnings growth in current year|Earnings per share growth rate in current year Ascentage Pharma Group AAPG|Earnings growth in current year CGON|Earnings growth in current year UroGen Pharma Ltd (URGN)|Earnings growth in current year BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth rate in current year|Erasca Oncology - Earnings growth in current year|DCTH: Earnings per share growth in current year|YMAB: Earnings growth in current year|Aura Bio (AURA) - Earnings growth in current year|CADL (Candel Therapeutics Inc.) - Earnings growth in current year|ARAY: Earnings per share increase in current year|Net earnings per share growth this year SLS (SELLAS Life Sciences Group, Inc.)|Net earnings per one share growth for the current year ACTU|Citius Oncology - Net earnings per share growth this year|Earnings per share increase in current year HURA|TARA: Net earnings per share growth this year|Earnings per share growth rate in current year Fate Pharma|Aadi Bioscience Inc (WHWK) - Earnings per share growth in current year|Earnings per share growth rate in current year TScan (TCRX)|Net earnings per share growth this year CSBR|xbiotech.com (XBIT) - Expected net earnings per share growth this year|Earnings per share growth in current year cel-sci.com (CVM)|OSTX - Earnings per share growth rate in current year|Radiopharm Theranostics - Net earnings per share growth this year|Earnings per share increase in current year ARTV|ANL - Earnings per share growth in current year|VERU - Earnings growth in current year|Tempest Therapeutics, Inc. (TPST) - Earnings per share growth in current year|XLO: Net earnings per one share growth for the current year|RENB (Renovaro Biosciences) - Earnings growth in current year|MURA: Earnings per share increase in current year|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|Net earnings per one share growth for the current year OKUR|CytoMed Therapeutics Limited - Net earnings per share growth this year|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma
